Calycosin Inhibits the Malignant Behaviors of Lung Adenocarcinoma Cells by Regulating the circ_0001946/miR-21/ GPD1L/HIF-1 α Signaling Axis

Objective . To clarify the potential function and molecular mechanism of calycosin in lung adenocarcinoma (LUAD) cells. Methods . LUAD cells (A549 and H1299) were treated with calycosin at di ﬀ erent concentrations (25 nM, 50nM, and 100nM) for 24 h. The colony formation, invasion, and migration of the cells were assessed by colony formation, transwell, and scratch assays, respectively. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to determine the mRNA expression level of circ_0001946, miR-21, glycerol-3-phosphate dehydrogenase 1 like (GPD1L), and hypoxia-inducible factor-1 α (HIF-1 α ) in clinical tissue samples and LUAD cells. RNA pull-down assay and dual-luciferase reporter assay were performed to verify the relationship among circ_0001946, miR-21, GPD1L, and HIF-1 α . Western blot was performed to detect the protein expression of epithelial-mesenchymal transition (EMT) process-related genes (E-cadherin, N-cadherin, and snail) and GPD1L as well as HIF-1 α . Results . Calycosin inhibited colony formation, invasion, migration, and EMT progression in A549 and H1299 cells. Besides, calycosin was able to regulate the expression of circ_0001946, miR-21, GPD1L, and HIF-1 α in LUAD cells. According to the ﬁ ndings of QRT-PCR, the expression level of circ_0001946 and GPD1L in LUAD tissues was signi ﬁ cantly lower than that in adjacent noncancerous normal tissues, and the expression of miR-21 and HIF-1 α was also signi ﬁ cantly increased in clinical tissue samples. In addition, there was a targeted regulatory relationship among the above four expressions. Knockdown of circ_0001946 expression in A549 cells treated with calycosin enhanced the malignant behavior of A549 cells and inhibited the anticancer e ﬀ ect of calycosin. However, the knockdown of miR-21 promoted the anticancer e ﬀ ect of calycosin and inhibited the malignant behavior of A549. Conclusion . Calycosin can inhibit colony formation, invasion, migration, and EMT process of LUAD cells via regulating the circ_0001946/miR-21/GPD1L/HIF-1 α signaling axis and could be a promising therapeutic drug for LUAD.


Introduction
As one of the cancers with the highest malignant degree, lung cancer is accompanied by a 4%-17% 5-year survival rate, making it the most common cause of cancer-related death worldwide [1]. Non-small-cell lung cancer (NSCLC) accounts for nearly 80% of lung cancers, including about 50% of lung adenocarcinoma (LUAD). The prevalence of LUAD is increasing annually and is about to become the main subtype of NSCLC [2]. Despite improvements in early diagnosis, patients with LUAD still have a low 5-year overall survival rate and unsatisfactory recurrence rate [3,4]. Currently, the clinical treatment protocols for LUAD mainly include drugs and radiotherapy; however, they are often prone to tolerance in patients [5]. It was reported that when treated with EGFR tyrosine kinase inhibitors (TKIs), gefitinib or erlotinib and osimertinib, most LUAD patients with EGFR mutations acquired drug resistance mutations [6].
Hence, it is essential to explore new therapeutic agents and elucidate their molecular mechanisms to develop new therapeutic strategies to treat LUAD.
Circular RNA (circRNA), an endogenous noncoding RNA with a covalently closed-loop structure but without a 5 ′ cap and 3 ′ polyadenylate tail, is resistant to exonucleases [7]. A large number of previous studies have confirmed the presence of circRNAs in a variety of diseases and cancers [8]. Some reports revealed the involvement and different roles of many circRNAs in the development of LUAD. For example, high circ_0023404 expression was shown to be associated with poor prognosis in lung cancer patients [9]. In addition, circ-RAD23B can promote cell growth and metastasis in NSCLC [10]. Relevant articles have indicated that circ_0001946 expression is downregulated in various cancers, such as the case of bladder cancer and glioblastoma [11]. Huang et al. [12] discovered that circRNA has_circ_ 0001946 inhibited lung cancer progression and mediated NSCLC cisplatin sensitivity through nucleotide excision repair. Notably, Yao et al. [13] claimed that circ_0001946 was also involved in LUAD development and was a potential biomarker for treating LUAD. It can be seen that circRNA is of vital significance in tumor progression, and circ_0001946 may be a potential target for the treatment of lung cancer. Further exploration is required for circ0001946 due to its complex function.
Great progress has been achieved in using extracts of traditional Chinese medicine (TCM) in treating cancer, which has emerged as a potential cancer therapy. Calycosin, a fatsoluble component in radix astragali (the dried roots of Astragalus membranaceus), is a commonly seen organic compound in nature, with antioxidant and antiinflammatory properties [14]. Recently, calycosin has attracted much attention due to the discovery of its anticancer effects. Wang et al. [15] found that calycosin inhibited the invasion and metastasis of colorectal cancer cells by regulating the epithelial-mesenchymal transition (EMT) of cells. Zhang et al. [16] proved that calycosin could inhibit pancreatic cancer cell growth by inducing cell cycle arrest and apoptosis and induce the metastatic progression of pan-creatic cancer by regulating the tumor microenvironment. Through the above findings, it can be speculated that calycosin is a potential anticancer drug. However, there are few studies on calycosin's role in treating LUAD. At present, Cheng et al. [17] discovered that calycosin was able to inhibit the proliferation and metastasis of human LUAD cells (A549). However, the mechanism of action of calycosin in inhibiting cancer remains to be uncovered, urging in-depth study.
Given the above limitations in literature, in this study, we attempted to investigate the effect and underlying mechanisms of calycosin on the progression of LUAD cells, including the effect on the expression and function of circ_ 0001946, with the aim of suggesting the potential significance of calycosin as a promising agent for the treatment of LUAD.

Disease Markers
penicillin, and 100 mg/mL streptomycin. The medium was placed in an incubator with 5% CO 2 at 37°C.
A549 and H1299 cells were treated with 25 nM, 50 nM, and 100 nM calycosin [15] for 24 h when the confluence reached 65%-80%. Then, subsequent functional assays were conducted. The circ_0001946 interfering fragment (si-circ_ 0001946) and its control (si-NC), miR-21 mimics and its control (miR-21 NC), and miR-21 inhibitor and its control inhibitor were designed and synthesized by GenePharma (Shanghai, China). Cells were seeded and cultured in 6well plates until their confluence reached 65%-80%. Subsequently, the above fragments or vectors were transfected into A549 and H1299 cells using Lipofectamine 2000 (Invitrogen, USA). After 48 h culture, the cells were collected. In addition, to verify the action mechanism of calycosin, A549 cells were first treated with 100 nM calycosin for 24 h and then transfected with miR-21 inhibitor and si-circ0001946.
2.3. Cell Cloning Assay. Cells with different treatments in the logarithmic growth phase were seeded in a 6-well cell culture plate at 500 cells/well; then, an incubator with 5% CO 2 was applied for cell culture at 37°C for approximately 14 days. Next, the cells were gently rinsed with PBS solution, fixed with 4% paraformaldehyde (Beyotime, China) for 30 min, and stained with crystal violet staining solution (Beyotime, China) for 10-30 min. Finally, the excess staining solution was washed off with PBS solution, and the number of colony formations was counted.

Transwell.
Matrigel was dissolved at 4°C and diluted according to a certain proportion. Then, the diluted Matrigel was added to the bottom of the transwell chamber and solidified in an incubator at 37°C. The cells in the logarithmic growth phase were digested and collected. After resuspension with a serum-free DMEM, the concentration of cell suspension was adjusted to 8 × 10 5 cells/mL. Subsequently, 100 μL of cell suspension was added to the transwell insert plated with Matrigel, and 600 μL of DMEM with 20% FBS was added to the lower chamber. Then, an incubator was used for incubation at 37°C for 20-24 h. After that, the insert was removed, and 4% paraformaldehyde was added for 30 min fixation. A cotton swab was used to wipe off residual cells in the insert; then, crystal violet staining solution was added for staining for 10-30 min. After the completion of staining, PBS solution was employed to wash off the excess staining solution. Under the microscope, random 5 fields were selected for picture collection and cell counting.

Scratch
Assay. The cells were seeded into 6-well plates at the density of 1 × 10 6 cells/well and incubated overnight to reach confluence. The scratch was created with a pipette tip, and the floating cells were cleared with PBS. Then, the 7 Disease Markers scratch was imaged under a microscope after 0 h and 12 h of culture in an incubator at 37°C. The scratch area was determined using ImageJ software, and the migration rate was calculated according to the migration area calculation formula: migration rate = ðA0 − AnÞ/A0, with A0 representing the initial scratch area and An representing the scratch area after 12 h.
2.6. Western Blot. The total protein was extracted from the cells with RIPA Lysing Solution (Beyotime, China) and then quantified by a BCA kit (Beyotime, China). Subsequently, 30 μL of total protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene fluoride (PVDF) membrane. Next, the membrane was blocked with 5% skimmed milk for 1-3 h at ambient temperature and then incubated with primary antibodies (anti-E-cadherin, anti-N-cadherin, anti-Snail, anti-HIF-1α, anti-GPD1L, and anti-β-actin, CST, USA) overnight at 4°C. Later, the membrane was washed three times with PBST and incubated with horseradish peroxidase-conjugated secondary antibodies (CST, USA) for 1 h at ambient temperature. Immunoreactive bands were developed using enhanced chemiluminescence reagents (Thermo, USA) and imaged by a ChemiDoc XRS Plus luminescent image analyzer (Bio-Rad). The grayscale was analyzed using Image-Pro Plus 6.0 software, and the relative expression level of the proteins was calculated with β-actin as an internal control due to its high stability as a housekeeping gene.

qRT-PCR.
TRizol method (Solarbio, China) was employed to extract total cellular and tissue RNA, followed by the detection of the concentration and purity of RNA with NanoDrop. Then, RNA was utilized to prepare cDNA according to the instructions of the random primer reverse transcription kit (Thermo, USA). The expression level of circ_0001946, miR-21, GPD1L, and HIF-1α in the cells was measured per the instructions of the SYBR Green kit (TaKaRa, Japan). U6 and GADPH served as internal controls, and six replicates were set up in the experiment. The experimental data obtained by qRT-PCR were used to calculate the relative expression of the target gene with the 2ˉΔ ΔCt method. Primer sequences are displayed in Table 1. 9 Disease Markers its control (miR-21-bio NC) were constructed, and biotinylated RNA was incubated with cell lysate at 4°C overnight. Agarose beads were then added for another 1 h incubation, and the expression of circ_0001946 in the precipitated complex was detected with qRT-PCR.
2.10. Data Analysis. The results are expressed as mean ± standard deviation (SD). The SPSS v26.0 and Graphpad Prism v9.0 software were used for statistical analysis. Oneway analysis of variance was used for comparison between multiple groups and an independent sample T-test for comparison between two groups. Pearson correlation was applied to analyze the expression correlation, and p < 0:05 was used to determine statistical significance.

Calycosin Inhibits Colony Formation, Invasion, Migration, and Epithelial-Mesenchymal Transition in Lung
Adenocarcinoma Cells. Calycosin is a natural compound with antioxidant and estrogenic activity, which has anticancer potential (Figure 1(a)). To explore the role of calycosin in LUAD, we treated LUAD cells (A549 and H1299) with different concentrations of calycosin (25 nM, 50 nM, and 100 nM). The colony formation, invasion, and migration ability of cells in each group were tested by cell colony formation, transwell, and scratch assays, respectively. The results revealed that the abilities of colony formation (Figures 1(b)-1(c)), invasion (Figures 1(d) and 1(e)), and migration (Figures 1(f) and 1(g)) of A549 and H1299 cells in the CA 25 nM group, CA 50 nM group, and CA 100 nM group were all significantly reduced in a concentrationdependent manner compared with the control group

11
Disease Markers (p < 0:01). Additionally, to understand the effects of calycosin on the EMT process of LUAD, we examined the expression level of EMT-related proteins in cells of each group using western blot. The results showed that calycosin could significantly increase the protein expression level of Ecadherin and decrease the level of N-cadherin and Snail in A549 and H1299 cells in a concentration-dependent manner (Figures 1(h)-1(j)). In summary, calycosin could significantly inhibit colony formation, invasion, migration, and EMT progression of LUAD cells.

Calycosin Upregulates circ_0001946 Level in Lung
Adenocarcinoma Cells. Aside from the above finding, we also discovered that calycosin could significantly increase the expression level of circ_0001946 in A549 and H1299 cells in LUAD in a concentration-dependent manner (p < 0:01, Figures 2(a) and 2(b)). However, it remained unclear whether calycosin inhibited LUAD cell colony formation, invasion, migration, and EMT process through circ_ 0001946. To figure this out, the expression of circ_0001946 in LUAD was examined by qRT-PCR. The results showed that the expression level of circ_0001946 in LUAD tissues was much lower than that in normal tissues (p < 0:01, Figure 2(c)); and similar results were also observed at the cellular level; that is, the expression level of circ_0001946 in A549 and H1299 cells in LUAD was significantly decreased compared with that in normal lung epithelial cells BEAS-2B (p < 0:01, Figure 2(d)). These results suggested that calycosin could inhibit the malignant behaviors of LUAD cells by upregulating circ_0001946.

circ0001946
Can Serve as a Sponge for miR-21. circRNAs can regulate signal transmission through molecular sponge microRNAs. However, it remained unknown whether upregulated circ_0001946 after calycosin treatment could play its role by sponging microRNAs. To verify this, miR-21 was predicted as a downstream target of circ_0001946 by bioinformatics analysis (Starbase.2). After calycosin treatment, the expression of miR-21 in A549 and H1299 cells was examined. The results showed that calycosin treatment was able to significantly downregulate the expression of miR-21 (Figures 3(a) and 3(b)), suggesting that calycosin could upregulate circ_0001946 by sponging miR-21. The expression of miR-21 in clinical samples was further evaluated, and the results indicated that miR-21 expression level in LUAD tissues was significantly elevated compared with adjacent normal tissues (p < 0:01, Figure 3(c)). Additionally, miR-21 expression was negatively correlated with circ_ 0001946 expression in LUAD tissues (Figure 3(d)). Therefore, we speculated that there was a targeting relationship between circ_0001946 and miR-21. Subsequently, the binding sites of miR-21 and circ0001946 were predicted, and the prediction outcomes are shown in Figure 3(e). Next, a luciferase reporter assay was performed in 293T cells to assess the relationship between miR-21 and circ0001946. According to the results, compared with the MUT group, cells in the WT group treated with miR-21 mimics presented lower luciferase activity (Figure 3(f)). RNA pull-down assay presented that circ_0001946 could bind to miR-21 (Figures 3(g) and 3(g)). After knockdown of circ_0008035 expression in A549 and H1299 cells by si-circ0001946,   In summary, our results showed that circ0001946 could be used as a sponge for miR-21.
3.4. miR-21 Can Target GPD1L. As a microRNA, miR-21 can target and bind mRNA to regulate the expression of genes and then exert biological functions. It could be observed in this study that calycosin was able to significantly increase GPD1L expression levels in A549 and H1299 cells (p < 0:01, Figures 4(a) and 4(b)). Then, the binding sites of miR-21 and GPD1L were predicted, and the specific results are shown in Figure 4(c). The targeting relationship between miR-21 and GPD1L was verified by a dual-luciferase reporter assay. Compared with the GPD1L-MUT group, we observed a much lower luciferase activity of cells in the GPD1L-WT group after the treatment of miR-21 mimics (Figure 4(d)). Subsequently, a negative correlation between miR-21 expression and GPD1L expression was discovered in LUAD clinical samples (Figure 4(e)). In addition, knockdown of miR-21 in A549 or H1299 cells was able to significantly upregulate the mRNA and protein expression level of GPD1L (Figures 4(f)-4(k)). The above findings suggested that GPD1L was a potential target gene of miR-21.

miR-21
Regulates the Level of HIF-1α through GPD1L. Interestingly, the level of bHLH-PAS family transcription factor HIF-1α in A549 and H1299 cells after calycosin treatment was significantly reduced compared with that in the control group in this study (p < 0:01, To determine whether calycosin inhibited the malignant behavior of LUAD cells through the circ_0001946/ miR-21/GPD1L/HIF-1α signaling axis, the cells treated by calycosin were transfected with si-circ0001946 or miR-21 inhibitor. Then, the abilities of colony formation, invasion, migration, and EMT process of A549 cells were assessed by colony formation assay, transwell, scratch assay, and western blot. The results are shown in Figure 6. We observed that compared with the CA group, the CA+si-circ_0001946 group presented a significant increase in colony formation, invasion, and migration abilities of A549 cells (p < 0:01), and at the same time, the EMT process of cells was also promoted (downregulation of E-cadherin, upregulation of Ncadherin and snail). When treatment with calycosin and transfection with miR-21 inhibitor (CA+inhibitor group) were performed simultaneously, the above phenotypes of A549 cells were reversed, showing markedly reduced abilities of colony formation, invasion, migration, and EMT process of A549 cells (p < 0:01, Figures 6(a)-6(f)). In addition, the GPD1L expression level in A549 cells in the CA+si-circ0001946 group was much lower than that in the CA group, while the level of HIF-1α was notably increased. The expression level of GPD1L in cells of the CA+inhibitor

15
Disease Markers group was significantly increased compared with that of the CA group, while the level of HIF-1α was significantly decreased (Figures 6(i)-6(l)). In summary, the circ0001946/miR-21/GPD1L/HIF-1α signaling axis was a key mediator of the anticancer function exerted by calycosin.

Discussion
In previous studies, Chinese herbal extracts have attracted researchers' interests due to their satisfactory anticancer properties, such as inhibiting cancer cell growth, proliferation, and differentiation [18]. Calycosin is a natural isoflavone isolated from Astragalus membranaceus, with antiinflammatory, antioxidant, and antitumor properties. Li et al. [19] reported that calycosin inhibited migration and invasion of human breast cancer cells by downregulating the expression of Foxp3. In addition, calycosin was shown to inhibit osteosarcoma cell migration and invasion [19]. In this study, it was demonstrated that calycosin could inhibit the proliferation, migration, invasion, and EMT progression of LUAD cells (A549, H1299) in a dose-dependent manner. These were generally consistent with the findings of Zhang et al. in breast cancer cells [20], indicating that calycosin could exert an inhibitory role in the progression of LUAD.
Recent studies have shown that cancer development is significantly correlated with the expression of noncoding RNAs [21]. Specifically, abnormal circRNA levels may affect the expression of specific genes and cause tumorigenesis or tumor progression [21]. Among circRNAs, circ_0001946 has been determined to involve various cancers, including LUAD [12]. Our study presented significantly downregulated circ0001946 expression in LUAD tumor tissues collected clinically, while calycosin could significantly upregulate circ_0001946 expression. Yao et al. [13] reported that circ_0001946 was significantly upregulated in LUAD tumor tissues, but Zhang et al. [22] found that the median expression level of circ_0001946 in NSCLC tissues was more than 3 times higher than that in tumor tissues. Besides, the expression of circ_0001946 in tumor tissues was also significantly lower than in tumor tissues in esophageal adenocarcinoma (ESCC) [23]. All in all, it is inconclusive whether circ_0001946 plays an anticancer or inhibitory role in malignant tumors since its expression may be affected by various factors.
It is reported that circRNAs can regulate biological processes through various action mechanisms, including "miRNA sponges," transcriptional regulation, protein binding, and translation [24]. Thereinto, miRNAs, small noncoding RNAs containing about 22 nucleotides, can regulate the expression of downstream target genes at the posttranscriptional level. According to recent studies, miRNAs are implicated in several physiological processes as well as tumorigenesis and metastasis of cancer [25,26]. Moreover, it was revealed that miR-21 is overexpressed in most cancers and plays a key role in cancer progression. For instance, Wang et al. [27] showed that miR-21 promoted LUAD cell proliferation, migration, and invasion by targeting WWC2. Du et al. [28] discovered that miR-21-5p promoted LUAD progression by regulating PIK3R1 expression. In this study, the significantly elevated expression level of miR-21 was observed in LUAD tumor samples, while calycosin could significantly downregulate the expression of miR-21. Aside from this, circ_0001946 showed a negative correlation with the expression of miR-21. Moreover, circ_0001946 could be used as a sponge of miR-21 via dual luciferase and RNA pull-down assays.
Reprogrammed energy metabolism is one of the hallmarks of cancer. Under aerobic glycolysis, cancer cells show glycolysis rather than oxidative phosphorylation, even in the presence of oxygen. Cancer cells can stop glycolysis to promote survival, growth, metastasis, stemness, drug resistance, long-term maintenance, and immune evasion of cancer cells [29]. Preceding studies have confirmed the presence of transcriptional regulators of aerobic glycolysis in cancer, for example, HIF-1α, c-MYC, and p53 [30]. GPD1L is a mediator involved in regulating aerobic glycolysis and can act as a tumor suppressor in cancer. It was shown that GPD1L inhibited prolyl hydroxylase activity and could hydroxylate proline in HIF-1α to promote its proteasomal degradation, thus exerting anticancer activity [31]. This study also revealed that miRNAs regulated GPD1L. Du et al. found that upregulated miR-210-3p in triple-negative breast cancer (TNBC) could target and inhibit the expression of GPD1L, then promote aerobic glycolysis in cells [32]. In this study, GPD1L expression was regulated by calycosin and miR-21, and a targeting relationship could be observed between miR-21 and GPD1L. After further investigation, miR-21 was found to be able to regulate HIF-1α level through GPD1L. Subsequently, in vitro experiments with knockdown of circ_0001946/miR-21 also confirmed that calycosin could regulate the proliferation, invasion, migration, and EMT of LUAD cells through the circ_0001946/miR-21/GPD1L/ HIF-1α signaling axis. Nevertheless, the exact mechanism of calycosin affecting the expression of circ_0001946 remains unclear up till now. In addition, we only researched the function and mechanism of calycosin in cells; thus, in vivo experiments and more studies are required to validate our findings and provide a more comprehensive theoretical basis for the clinical application of calycosin.

Conclusion
Calycosin inhibited colony formation, invasion, migration, and EMT progression of LUAD cells through the circ_ 0001946/miR-21/GPD1L/HIF-1α signaling axis in a concentration-dependent manner and demonstrated the potential to be an effective therapeutic agent for the treatment of LUAD.

Data Availability
The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest
The authors declare that they have no competing interests. 16 Disease Markers